2021
Risk reduction and pharmacological strategies to prevent progression of aortic aneurysms
Weininger G, Chan SM, Zafar M, Ziganshin BA, Elefteriades JA. Risk reduction and pharmacological strategies to prevent progression of aortic aneurysms. Expert Review Of Cardiovascular Therapy 2021, 19: 619-631. PMID: 34102944, DOI: 10.1080/14779072.2021.1940958.Peer-Reviewed Original ResearchConceptsAortic aneurysmAbdominal aortic aneurysmß-blockersAngiotensin II receptor blockersAngiotensin-converting enzyme inhibitorAnti-platelet medicationDifferent pharmacologic therapiesII receptor blockersAortic aneurysm patientsThoracic aortic aneurysmRisk reductionAortic aneurysm growthPharmacologic managementReceptor blockersPharmacologic therapyMedical therapySurgical interventionAneurysm patientsMiscellaneous drugsAneurysm diseasePharmacological strategiesSyndrome patientsMarfan syndromeEnzyme inhibitorsAneurysms
2017
Natural history of aortic root aneurysms in Marfan syndrome.
Saeyeldin A, Zafar MA, Velasquez CA, Ip K, Gryaznov A, Brownstein AJ, Li Y, Rizzo JA, Erben Y, Ziganshin BA, Elefteriades JA. Natural history of aortic root aneurysms in Marfan syndrome. Annals Of Cardiothoracic Surgery 2017, 6: 625-632. PMID: 29270374, PMCID: PMC5721101, DOI: 10.21037/acs.2017.11.10.Peer-Reviewed Original ResearchAortic root aneurysmAortic root diameterAortic dissectionRoot aneurysmMFS patientsAortic complicationsAdverse eventsAortic rootNatural historyRisk of complicationsAortic root dilatationMarfan syndrome patientsLogistic regression modelsAortic regurgitationCardiovascular complicationsHemodynamic roleDreadful complicationRoot dilatationAortic diameterLarge aneurysmsSyndrome patientsMarfan syndromeComplicationsPatientsAneurysms